Results 141 to 150 of about 295,792 (196)

LncRNA OTUD6B-AS1 overexpression induces parthanatos in esophageal adenocarcinoma cells by binding to miR-145-5p and promoting AIF expression. [PDF]

Am J Transl Res
Zheng Q, Wu Q, Lin Y, Chen X.
europepmc   +1 more source

Single-cell and bulk omics uncover fibroblast heterogeneity and HSPH1 as a key driver in Barrett's esophagus to esophageal adenocarcinoma progression. [PDF]

Cancer Cell Int
Tao L, Guo Y, Lu F, Qi C, Zhang G, Yan J.   +5 more
europepmc   +1 more source

Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma. [PDF]

Nat Med
Zamani SA, Wu L, Black EL, Bartram A, Ng AWT, Secrier M, Perelman JD, Ustaoglu A, Ococks E, Jacobson D, Devonshire G, Grehan N, Nützinger B, Freeman A, Miremadi A, O'Donovan M, Frankell AM, Killcoyne S, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Coleman HG, Fitzgerald RC.   +20 more
europepmc   +1 more source

Proteomic characterization of SMARCA-deficient esophageal adenocarcinoma reveals complement evasion and DNA repair-associated prognostic subgroups. [PDF]

Br J Cancer
Grothey B, Krämer M, Montalbano M, Lyu SI, Bruns CJ, Zander T, Büttner R, Quaas A.   +7 more
europepmc   +1 more source

Evolving challenges in the management of early esophageal adenocarcinoma: from clinical staging to molecular insights. [PDF]

World J Surg Oncol
Giorgi L, Garbarino GM, De Martino R, Pansa A, Casiraghi M, Basato S, Alfieri R, Castoro C.   +7 more
europepmc   +1 more source

Targeting APE1-Redox Function Reverses SOX9-mediated Chemoresistance in Esophageal Adenocarcinoma. [PDF]

Gastroenterology
Lu H, Ballout F, Chen L, Peng D, Chen Z, Soutto M, Cao L, Thangaretnam K, Gokulan RC, Wang TC, Que J, Giordano S, Washington MK, Chen XS, Sun X, Ban Y, McDonald OG, Zaika A, El-Rifai W.   +18 more
europepmc   +1 more source

Case Report: Successful treatment of mismatch repair-deficient cervical esophageal adenocarcinoma with immune checkpoint inhibition. [PDF]

Front Oncol
Dou A, Jin CJ, Maziak D, Gilbert S, Sim J, Leung E, Rushton M.   +6 more
europepmc   +1 more source

Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategy. [PDF]

Oncogene
Pinto R, Sjurgard IV, Pharo H, Mala T, Vedeld HM, Lind GE.   +5 more
europepmc   +1 more source

Angiotensin system inhibitors as adjunctive therapy in esophageal adenocarcinoma: hypothesis-generating insights from incidental use during trimodal treatment. [PDF]

Transl Cancer Res
Carmona-Bayonas A, Jimenez-Fonseca P.
europepmc   +1 more source

Editorial: Modelling esophageal adenocarcinoma

Frontiers in Molecular Biosciences
Hisham F. Bahmad, Farah Ballout
openaire   +3 more sources